Recurrent Ovarian Cancer Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer
Treatment of Recurrent Ovarian Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University40 enrolled1 locationNCT07286240
Recruiting
Phase 1
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Advanced Solid TumorPlatinum-resistant Recurrent Ovarian Cancer
Ascentage Pharma Group Inc.50 enrolled1 locationNCT06687070